Research Article

Additional Treatment with Low-Molecular-Weight Heparin Provides a Better Patient Outcome for Neonatal Pulmonary Hemorrhage with Unfractionated Heparin Treatment

Table 2

The FEV1, FEV1/FVC, and PEF of each patient in the observation and control group before and after unfractionated heparin treatment with or without additional low-molecular-weight heparin treatment.

GroupTimeFEV1 (L)FEV1/FVC (%)PEF (L/s)

Control group ()Before treatment
After treatment
2.5865.1723.857
0.0120.0070.014
Observation group ()Before treatment
After treatment
3.1258.6355.173
0.0210.0010.001

The symbol of indicates compared with the control group; FEV1: the first second forced expiratory volume; FVC: forced vital capacity; PEF: peak expiratory flow.